Anna Maria Cernigoi

1.1k total citations
10 papers, 698 citations indexed

About

Anna Maria Cernigoi is a scholar working on Endocrinology, Diabetes and Metabolism, Pharmacology and Molecular Biology. According to data from OpenAlex, Anna Maria Cernigoi has authored 10 papers receiving a total of 698 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Endocrinology, Diabetes and Metabolism, 3 papers in Pharmacology and 2 papers in Molecular Biology. Recurrent topics in Anna Maria Cernigoi's work include Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers), Pharmacology and Obesity Treatment (2 papers) and Diabetes Treatment and Management (2 papers). Anna Maria Cernigoi is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers), Pharmacology and Obesity Treatment (2 papers) and Diabetes Treatment and Management (2 papers). Anna Maria Cernigoi collaborates with scholars based in Italy. Anna Maria Cernigoi's co-authors include Mario Velussi, Paola Fioretto, Cristina Caffau, Marino Bruseghin, Michele Mussap, Michele Dalla Vestra, Alois Saller, Mario Plebani, Pietro Gallina and R. Nosadini and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes and Journal of the American Society of Nephrology.

In The Last Decade

Anna Maria Cernigoi

10 papers receiving 662 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Maria Cernigoi Italy 8 234 194 150 145 121 10 698
Maribel Chávez Venezuela 11 238 1.0× 146 0.8× 236 1.6× 49 0.3× 95 0.8× 13 783
Anwar Parbtani Canada 20 151 0.6× 189 1.0× 75 0.5× 49 0.3× 161 1.3× 39 1.0k
Kazushi Uneda Japan 17 288 1.2× 135 0.7× 310 2.1× 57 0.4× 207 1.7× 58 802
Bryna S.M. Chow Australia 10 216 0.9× 276 1.4× 177 1.2× 90 0.6× 326 2.7× 12 1.0k
Daniela Lucchesi Italy 13 186 0.8× 183 0.9× 164 1.1× 62 0.4× 125 1.0× 37 659
B A Leatherdale United Kingdom 18 462 2.0× 70 0.4× 219 1.5× 44 0.3× 128 1.1× 34 900
Renzo Schiavon Italy 18 81 0.3× 169 0.9× 74 0.5× 63 0.4× 81 0.7× 40 815
Lucas Opazo-Ríos Spain 12 200 0.9× 291 1.5× 75 0.5× 72 0.5× 347 2.9× 20 1.0k
Ryu Kobayashi Japan 15 162 0.7× 93 0.5× 227 1.5× 44 0.3× 125 1.0× 42 521
Vajir Malek India 18 147 0.6× 101 0.5× 230 1.5× 45 0.3× 277 2.3× 28 764

Countries citing papers authored by Anna Maria Cernigoi

Since Specialization
Citations

This map shows the geographic impact of Anna Maria Cernigoi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Maria Cernigoi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Maria Cernigoi more than expected).

Fields of papers citing papers by Anna Maria Cernigoi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Maria Cernigoi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Maria Cernigoi. The network helps show where Anna Maria Cernigoi may publish in the future.

Co-authorship network of co-authors of Anna Maria Cernigoi

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Maria Cernigoi. A scholar is included among the top collaborators of Anna Maria Cernigoi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Maria Cernigoi. Anna Maria Cernigoi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Vestra, Michele Dalla, Michele Mussap, Pietro Gallina, et al.. (2005). Acute-Phase Markers of Inflammation and Glomerular Structure in Patients with Type 2 Diabetes. Journal of the American Society of Nephrology. 16(3_suppl_1). S78–S82. 251 indexed citations
2.
Brocco, Enrico, Mario Velussi, Anna Maria Cernigoi, et al.. (2002). Evidence of a threshold value of glycated hemoglobin to improve the course of renal function in type 2 diabetes with typical diabetic glomerulopathy.. PubMed. 14(6). 461–71. 14 indexed citations
3.
Velussi, Mario, et al.. (1999). Atorvastatin for the management of Type 2 diabetic patients with dyslipidaemia. A mid-term (9 months) treatment experience.. PubMed. 12(6). 407–12. 25 indexed citations
5.
Velussi, Mario, Enrico Brocco, Francesco Frigato, et al.. (1996). Effects of Cilazapril and Amlodipine on Kidney Function in Hypertensive NIDDM Patients. Diabetes. 45(2). 216–222. 125 indexed citations
6.
Velussi, Mario, et al.. (1996). Therapeutic effect of benfluorex in type II diabetic patients on diet regimen alone. Journal of Diabetes and its Complications. 10(5). 261–266. 3 indexed citations
7.
Velussi, Mario, et al.. (1993). Silymarin reduces hyperinsulinemia, malondialdehyde levels, and daily insulin need in cirrhotic diabetic patients. Current Therapeutic Research. 53(5). 533–545. 26 indexed citations
8.
Velussi, Mario, et al.. (1993). Treatment of arterial hypertension in non-insulin-dependent diabetic patients: Comparison of doxazosin and enalapril. Current Therapeutic Research. 53(3). 316–328. 2 indexed citations
9.
Fioretto, Paola, Roberto Trevisan, Mario Velussi, et al.. (1987). Glomerular Filtration Rate is Increased in Man by the Infusion of Bothd,l-3-Hydroxybutyric Acid and Sodiumd,l-3-Hydroxybutyrate*. The Journal of Clinical Endocrinology & Metabolism. 65(2). 331–338. 34 indexed citations
10.
Trevisan, Roberto, R. Nosadini, Angelo Avogaro, et al.. (1986). Type I Diabetes is Characterized by Insulin Resistance Not Only with Regard to Glucose, but also to Lipid and Aminoacid Metabolism*. The Journal of Clinical Endocrinology & Metabolism. 62(6). 1155–1162. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026